-
Mashup Score: 25Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve - DurAVR - 1 day(s) ago
Preliminary results from a first-in-human study evaluating the novel DurAVR transcatheter heart valve in 13 patients with severe aortic stenosis showed good safety and sustained haemodynamic performance up to 1 year, with restoration of normal aortic blood flow patterns.
Source: eurointervention.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 61
A study of 40 patients undergoing a transcatheter procedure for tricuspid regurgitation found a high rate of post-procedure esophageal and gastric lesions, predominantly in the mid-esophagus, highlighting an underappreciated risk of probe manipulation during the procedure.
Source: eurointervention.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 56Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry - 16 day(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 0
Find out more about this article on Immediate or staged complete revascularisation in patients presenting with acute coronary syndrome by number of diseased vessels: a substudy of the BIOVASC randomised trial
Source: eurointervention.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 92Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy - 26 day(s) ago
This study used CT scans from a TAVI trial to assess feasibility of redo-TAVI by virtually implanting a second valve within original Evolut valves, finding lowest risks with positioning a SAPIEN 3 outflow at node 4 of the original frame.
Source: eurointervention.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 144Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation - 1 month(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet-
This new study suggests that TAVI can effectively reduce mitral regurgitation severity and symptoms in patients with atrial and ventricular functional mitral regurgitation, but the reduction is less pronounced in patients with primary mitral regurgitation. https://t.co/ot8RpgSy0u https://t.co/YaeyVkvfoJ
-
-
Mashup Score: 1
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 73Percutaneous interventions for pulmonary embolism - 1 month(s) ago
Find out more about this article on Percutaneous interventions for pulmonary embolism
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet-
everything you would like to know about percutaneous treatment of acute pulmonary embolism, but you never asked. now you can read this well written state-of-the-art @EuroInterventio @DFCapodanno @drgocchipinti @PCRonline @EAPCIPresident @TCTMD @OPCILive https://t.co/XE7BtADV26 https://t.co/JotVIEt9u3
-
-
Mashup Score: 24Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI - 1 month(s) ago
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Source: eurointervention.pcronline.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 47Prophylactic stenting of vulnerable plaques: pros and cons - 2 month(s) ago
This article discusses the potential and limitations of preventive stenting of vulnerable plaques identified on intravascular imaging to reduce acute coronary syndrome risk, but larger randomized trials are needed given imaging and stenting risks.
Source: eurointervention.pcronline.comCategories: General Medicine News, CardiologistsTweet
The DurAVR transcatheter heart valve was evaluated in a first-in-human study for treating symptomatic severe aortic stenosis. The study demonstrated a good safety profile and promising haemodynamic performance sustained at 1 year. #EIJBestOf https://t.co/bIaghkZDpA https://t.co/RoXIRILQMJ